Salute e Benessere

US Computer Vision in Healthcare Market worth US$11.53 billion by 2029 with…

Browse in-depth TOC on "US Computer Vision in Healthcare Market"294 - Tables46 - Figures356 - Pages Browse in-depth TOC on "US Computer Vision in Healthcare Market" 294 - Tables 46 - Figures 356 - Pages By Based on type,PC-based computer vision systems hold the largest share in the US computer vision in healthcare market due to their powerful, affordable, and dependable solutions for diagnostic centers and hospitals. With their ability to handle complex image analysis and…
PR Newswire
11/04/2025

SciBase launches next generation Nevisense

"I am proud to announce the launch of our next generation of Nevisense," said Pia Renaudin, CEO of SciBase. "This newly released version includes several exciting features and enhancements. We have also strategically prepared the platform for future expansion into new markets and clinical indications. " I am proud to announce the launch of our next generation of Nevisense," saidPia Renaudin, CEO of SciBase. " This newly released version includes several exciting…
PR Newswire
11/04/2025

Djerf Avenue announces appointment of Interim CEO, Nanna Hedlund following…

With over 20 years of executive leadership in top management positions across the beauty, fashion, home furnishings, and activewear industries (Kicks, Royal Design, Polarn O. Pyret, and Casall), Nanna Hedlund brings extensive experience to her role as CEO. She has built a distinguished career leading omnichannel growth journey across multiple markets - including retail presence in the US, as part of Polarn O. Pyret's broader global expansion strategy. She is known for driving growth, brand…
PR Newswire
11/04/2025

IM Cannabis Provides Corporate Updates

Nasdaq Notification Letter The Company has received a written notification (the " Notification Letter ") from the Nasdaq Stock Market LLC (" Nasdaq ") dated April 9, 2025, notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5550(b)(1). Nasdaq Listing Rule 5550(b)(1) (the " Listing Rule ") requires companies listed on the Nasdaq Capital Market to maintain a minimum ofUS$2.5 millionin stockholders' equity for continued listing. In the…
PR Newswire
11/04/2025

Global surgeons call for 'Natural Breast Beauty' in wake of rising aesthetic…

With breast augmentation now almost $3 billion global industry growing at 7.5% annually, experts warn that the trend toward hyper-curated aesthetics - amplified by social media - risks prioritizing trends over health and harmony. The new consensus provides a science-based framework for natural outcomes tailored to each woman's anatomy and long-term well-being. With breast augmentation now almost$3 billionglobal industry growing at 7.5% annually, experts warn that the trend toward...
PR Newswire
11/04/2025

SOTHEBY'S MAISON DEBUTS 'A VANITAS'

HONG KONG, April 11, 2025 /PRNewswire/ -- On a chance encounter during a flight from Los Angeles to London, British jeweller Hannah Martin spotted Guy Berryman — Coldplay bassist and founder of fashion label APPLIED ART FORMS—wearing one of her early designs. As fate would have it, Berryman had been planning a foray into jewellery for his contemporary clothing brand. This serendipitous meeting sparked A Vanitas, a collaboration born of mutual respect for elevated design and meticulous…
PR Newswire
11/04/2025

Dr. Suwelack Unternehmensstiftung Launches Annual Award to Promote Innovation in…

The evaluation committee, chaired by Prof. Dr. med Adrian Dragu, includes distinguished experts such as Dr.Isaac Angele from the Dr. Suwelack Corporate Foundation, medical and scientific experts Dr. med Volker Schmidt, Dr. med. Britta Wallner, and Dr. med. Enrique Monclús as well as MedSkin Solutions Dr. Suwelack AG representatives Diana Ferro, President and CEO, Dr. Claudia Doberenz and Dr. Ali Shahmoradi. The evaluation committee, chaired by Prof. Dr. med Adrian Dragu, includes...
PR Newswire
11/04/2025

Fagron publishes agenda for 2025 annual shareholders meeting

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2025 – 8 AM CET Fagron publishes agenda for 2025 annual shareholders meeting The Board of Directors of Fagron NV invites shareholders to attend Fagron's annual general meeting of shareholders on Monday 12 May 2025. AgendaThe agenda includes the discussion of the annual report, the approval of the annual financial statements and the dividend proposal of €0.35 for the financial year 2024, and the approval of...
Nasdaq GlobeNewswire
11/04/2025

CARBIOS announces fiscal-year 2024 financial results

Cash of €109 million on December 31, 2024PET biorecycling plant in Longlaville: adjusted schedule and confirmed intention for construction resumption once additional financing has been securedSignificant progress made towards signing several binding commercial contracts in first half of 2025Roll-out of a reorganization and cost-cutting plan in 2025: cash-burn reduced by 40% and strategic capabilities maintainedClermont-Ferrand (France), 11 April 2025 (6:45 am CEST)...
Nasdaq GlobeNewswire
11/04/2025

BioVaxys Technology Corp. Announces Revocation of Management Cease Trade Order…

The issuance of the revocation order on March 20, 2025, follows the filing by the Company of its audited annual financial statements for the year ended October 31, 2024, the related management's discussion and analysis, and its Form 52-109FV1 CEO and CFO Certifications of Annual Filings (collectively, the "Required Filings") on March 19, 2025. The issuance of the revocation order onMarch 20, 2025, follows the filing by the Company of its audited annual financial statements for the year…
PR Newswire
11/04/2025

XENICAL Strengthens Market Position as Obesity Rates Surge Worldwide |…

Genentech's XENICAL (orlistat) Overview Genentech's XENICAL (orlistat) Overview XENICAL (orlistat), developed by Genentech (a Roche subsidiary), is a powerful, specific, and reversible gastrointestinal lipase inhibitor. Orlistat acts as a reversible inhibitor of gastrointestinal lipases, working within the stomach and small intestine. It binds covalently to the active serine site of gastric and pancreatic lipases, rendering them inactive and preventing the breakdown of dietary...
PR Newswire
10/04/2025

Air New Zealand unveils new uniform: A bold celebration of Aotearoa, artistry…

Worn by 6,000 Air New Zealanders around the world, Air New Zealand's uniforms have always been a core part of its identity. The airline's uniforms are known for being bold, creative, and instantly recognisable, a tradition Emilia and Te Rangitu's design continues. Worn by 6,000 Air New Zealanders around the world, Air New Zealand's uniforms have always been a core part of its identity. The airline's uniforms are known for being bold, creative, and instantly recognisable, a tradition Emilia…
PR Newswire
10/04/2025

Genmab A/S Share Capital Reduction

Company Announcement COPENHAGEN, Denmark; April 10, 2025 –Genmab A/S(Nasdaq: GMAB) At Genmab A/S' Annual General Meeting on March 12, 2025, it was decided to reduce the Company's share capital with nominally DKK 2,076,853 by cancellation of 2,076,853 of the Company's holding of shares with a nominal value of DKK 1 each.The share capital reduction has today been registered with the Danish Business Authority. Genmab's share capital will be updated in Nasdaq's system as soon as...
Nasdaq GlobeNewswire
10/04/2025

Tecan reports key outcomes from Annual General Meeting 2025

Tecan reports key outcomes from Annual General Meeting 2025 Stable dividend of CHF 3.00 per shareLukas Braunschweiler, Myra Eskes, Oliver Fetzer, Matthias Gillner, Christa Kreuzburg, Monica Manotas and Daniel R. Marshak re-elected as members of the Board of DirectorsLukas Braunschweiler confirmed by shareholders as Chair of the BoardMyra Eskes, Christa Kreuzburg and Daniel R. Marshak confirmed as members of the Compensation CommitteeShareholders approved the maximum...
Nasdaq GlobeNewswire
10/04/2025

Okeiro raises €10 Million to accelerate development of its Precision Medicine…

Okeiro raises €10 Million to accelerate development of its Precision Medicine platform for Transplantation and Chronic DiseasesParis, April 10, 2025– Okeiro, a company specializing in precision medicine for transplantation and advanced chronic diseases, today announces a €10 million funding round to accelerate its deployment in France and internationally. This financing round is led by Alven, Forepont Capital Partners and Red River West. Technology for point of care and clinical...
Nasdaq GlobeNewswire
10/04/2025

Global Pharma Organization Implements Advanced Signals as Part of LifeSphere…

LifeSphere Advanced Signals, powered by NavaX, delivers measurable impact, including: LifeSphere Advanced Signals, powered by NavaX, delivers measurable impact, including: By integrating LifeSphere Advanced Signals into their global safety ecosystem, this leading organization is better positioned to drive faster and more precise signaling, improve patient safety, and streamline pharmacovigilance workflows. "We continue to see life sciences organizations prioritizing advanced...
PR Newswire
10/04/2025

US Ablation Technology Market worth US$3.87 billion by 2030 with 9.6% CAGR |…

Browse in-depth TOC on "US Ablation Technology Market" Browse in-depth TOC on "US Ablation Technology Market" 200 - Tables 25 - Figures By Based on segment,In the US, the pulsed field ablation market is poised to be the fastest growing technology segment owing to their superior safety profile (as compared to thermal ablation), rising prevalence of CVDs along with rising adoption of PFA in fibrillation treatment, and supportive regulations. By Based on application, the US...
PR Newswire
10/04/2025

Smart Appliances Market to Reach $93.03 Billion by 2032, Growing at a CAGR of…

Browse in-depth scope of Smart Appliances Market Report:358 – Tables32 – Figures360 – Pages Browse in-depth scope of Smart Appliances Market Report: 358 – Tables 32 – Figures 360 – Pages For more comprehensive insights, download the FREE report sample: https://www.meticulousresearch.com/download-sample-report/cp_id=6153 KEY MARKET DRIVERS AND TRENDS The smart appliances market is experiencing rapid growth due to increasing consumer demand for...
PR Newswire
10/04/2025

Global Organ on a Chip Market Valuation is Poised to Surpass 2,238.28 Million by…

By 2024, recent real-world milestones underscore how organ-on-chip technology has shifted from an academic pursuit to a bona fide industry disruptor—one increasingly validated by regulatory authorities. Emulate, Inc.'s collaboration with the U.S. Food and Drug Administration (FDA) exemplifies this evolution. In 2021, FDA scientists joined a pilot program assessing Emulate's Liver-Chip to predict drug-induced liver injury, following earlier collaborations focusing on Intestine-Chip devices for…
PR Newswire
10/04/2025

Longevity and precision medicine driving the agenda at Abu Dhabi Global Health…

The initiative is designed to drive the widespread adoption of personalised healthcare approaches and promote research into extending healthy lifespans. This call to action comes at a pivotal moment, as global life expectancy has more than doubled to 71 years, yet the gap between healthspan and lifespan has widened to 9.6 years, meaning many people spend nearly a decade of their lives in poor health as a result of chronic diseases. The initiative is designed to drive the widespread adoption…
PR Newswire
10/04/2025

Selskabsmeddelelse 13 med vedhæftede fil

Selskabsmeddelelse 13/2025 10. april 2025 BESTYRELSESMEDLEMMERS, DIREKTØRERS ELLER NÆRTSTÅENDE PERSONERS HANDEL MED STRATEGIC PARTNERS A/S AKTIERSe venligst vedlagte. Attachments Selskabsmeddelelse 13_2025_Bestyrelsesmedlemmers Direktørers eller nærtstående personers...
Nasdaq GlobeNewswire
10/04/2025

Election of Auditor and Indipendent Sustainablity Reporting Assurance Service…

UAB “Vilniaus prekyba” being the sole shareholder of MAXIMA GRUPĖ, UAB (hereinafter – the Company) adopted resolution appointing PricewaterhouseCoopers, UAB (legal entity code 111473315) as the audit firm of the Company to perform the audit of the annual financial statements of the Company and the audit of the annual consolidated financial statements of the Company for the years 2025, 2026 and 2027. Moreover, PricewaterhouseCoopers, UAB was elected as the consolidated sustainability reporting...
Nasdaq GlobeNewswire
10/04/2025

Evaxion to present at World Vaccine Congress

Congress will take place April 21-24, 2025, in Washington, D.C. COPENHAGEN, Denmark, April 10, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will give two presentations and man a booth at the World Vaccine Congress taking place April 21-24, 2025, in Washington, D.C.Birgitte Rønø, Chief Scientific Officer at Evaxion, will talk about the application of Evaxion's AI-Immunology™...
Nasdaq GlobeNewswire
10/04/2025

Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical…

Interim blinded safety and pharmacokinetic data to be presented at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) /2a randomized, double-blinded, placebo-controlled clinical trial of SYN-004 (ribaxamase) in allogeneic hematopoietic cell transplant (HCT) recipients for the prevention of acute graft-versus-host-disease (aGVHD). These data will be featured in an ePoster Flash Session oral presentation at the Congress of the European Society...
Nasdaq GlobeNewswire
10/04/2025
Altri  Comunicati